SUPPRESSING CHOLESTATIC FIBROTIC PROGRESSION BY TARGETING JCAD IN HEPATIC STELLATE CELLS

被引：0
|
作者：
Xie, Li [1 ]
Chen, Hui [1 ]
Zhou, Yuan [1 ]
Zhang, Li [1 ]
Yang, Yongyu [1 ]
Liu, Xiuping [2 ]
Wu, Jian [1 ,3 ,4 ]
机构：
[1] Fudan Univ, Sch Basic Med Sci, Dept Med Microbiol, Shanghai 200032, Peoples R China
[2] Fudan Univ, Shanghai Peoples Hosp 5, Sch Basic Med Sci, Dept Pathol, Shanghai 200032, Peoples R China
[3] Fudan Univ, Zhongshan Hosp, Dept Gastroenterol & Hepatol, Shanghai, Peoples R China
[4] Fudan Univ, Shanghai Inst Liver Dis, Shanghai Med Coll, Shanghai 200032, Peoples R China
来源：
HEPATOLOGY | 2023年 / 78卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
4575-C
引用
收藏
页码：S2074 / S2075
页数：2
相关论文
共 50 条
  • [1] JCAD deficiency attenuates activation of hepatic stellate cells and cholestatic fibrosis
    Xie, Li
    Chen, Hui
    Zhang, Li
    Ma, Yue
    Zhou, Yuan
    Yang, Yong -Yu
    Liu, Chang
    Wang, Yu -Li
    Yan, Ya-Jun
    Ding, Jia
    Teng, Xiao
    Yang, Qiang
    Liu, Xiu-Ping
    Wu, Jian
    CLINICAL AND MOLECULAR HEPATOLOGY, 2024, 30 (02) : 206 - 224
  • [2] SUPPRESSING MASH FIBROTIC PROGRESSION BY BLOCKING SUCCINATE-GPR91 SIGNALING AXIS IN HEPATIC STELLATE CELLS
    Wu, Jian
    Xie, Li
    Chen, Hui
    Zhang, Li
    Yang, Yong-Yu
    Liu, Xiu-Ping
    HEPATOLOGY, 2024, 80 : S1539 - S1540
  • [3] Docosahexaenoic Acid Supplementation Abrogated Fibrotic Progression in Nonalcoholic Steatohepatitis By Suppressing Activation of Hepatic Stellate Cells through GPR91
    Liu, Xuejing
    Niu, Chen
    Wu, Jian
    HEPATOLOGY, 2018, 68 : 441A - 441A
  • [4] A critical review on anti-fibrotic phytochemicals targeting activated hepatic stellate cells
    Vijayan, Nivya
    Perumal, Madan Kumar
    JOURNAL OF FOOD BIOCHEMISTRY, 2022, 46 (12)
  • [5] Novel Nano-Based Drug Delivery Systems Targeting Hepatic Stellate Cells in the Fibrotic Liver
    Ezhilararasan, Devaraj
    Lakshmi, Thangavelu
    Raut, Biond
    JOURNAL OF NANOMATERIALS, 2021, 2021
  • [6] Identification of cromolyn sodium as an anti-fibrotic agent targeting both hepatocytes and hepatic stellate cells
    Choi, Joon-Seok
    Kim, Jun Ki
    Yang, Yoon Jung
    Kim, Yeseul
    Kim, Pilhan
    Park, Sang Gyu
    Cho, Eun-Young
    Lee, Dae Ho
    Choi, Jin Woo
    PHARMACOLOGICAL RESEARCH, 2015, 102 : 176 - 183
  • [7] Anti-fibrotic effect of thymoquinone on hepatic stellate cells
    Ghazwani, Mohammed
    Zhang, Yifei
    Gao, Xiang
    Fan, Jie
    Li, Jiang
    Li, Song
    PHYTOMEDICINE, 2014, 21 (03) : 254 - 260
  • [8] Transcriptome-based repurposing of apigenin as a potential anti-fibrotic agent targeting hepatic stellate cells
    Daniel F. Hicks
    Nicolas Goossens
    Ana Blas-García
    Takuma Tsuchida
    Benjamin Wooden
    Michael C. Wallace
    Natalia Nieto
    Abigale Lade
    Benjamin Redhead
    Arthur I Cederbaum
    Joel T. Dudley
    Bryan C. Fuchs
    Youngmin A. Lee
    Yujin Hoshida
    Scott L. Friedman
    Scientific Reports, 7
  • [9] Transcriptome-based repurposing of apigenin as a potential anti-fibrotic agent targeting hepatic stellate cells
    Hicks, Daniel F.
    Goossens, Nicolas
    Blas-Garcia, Ana
    Tsuchida, Takuma
    Wooden, Benjamin
    Wallace, Michael C.
    Nieto, Natalia
    Lade, Abigale
    Redhead, Benjamin
    Cederbaum, Arthur I.
    Dudley, Joel T.
    Fuchs, Bryan C.
    Lee, Youngmin A.
    Hoshida, Yujin
    Friedman, Scott L.
    SCIENTIFIC REPORTS, 2017, 7
  • [10] Fluorofenidone attenuates hepatic fibrosis by suppressing the proliferation and activation of hepatic stellate cells
    Peng, Yu
    Yang, Huixiang
    Wang, Nasui
    Ouyang, Yan
    Yi, Yanrong
    Liao, Litao
    Shen, Hong
    Hu, Gaoyun
    Wang, Zhaohe
    Tao, Lijian
    AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY, 2014, 306 (03): : G253 - G263
12345